Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-001471-11Phase 4Terminated
Phase 4, randomised trial of polidocanol in hemorrhoid (2 arms), sponsored by Kreussler. Primary endpoints: Absence of bleeding during or directly after defecation 4 weeks after last sclerotherapy and Safety: occurrence of adverse drug reactions. Started Aug 2007; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-001471-11.